MXMingrong Xi

Mingrong Xi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mingrong Xi has a total of 158 co-authors. Here are the top co-authors by number of shared publications:

  • Bin Zhou

    Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education

    8 shared publications
  • Danxi Zheng

    Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu, China

    7 shared publications
  • Kaige Pei

    Department of Obstetrics and Gynecology West China Second University Hospital of Sichuan University Chengdu China

    6 shared publications
  • Mengyin Ao

    Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu, China

    6 shared publications
  • Yaping Song

    Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education

    6 shared publications
  • Di You

    Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Number 20, Third Section of People's South Road, Chengdu, 610000, China

    5 shared publications

Latest Publications

  • Open Access

    Nomogram for Preoperative Prediction of Adjuvant Therapy Requirement Following Radical Surgery in Stage IB Cervical Squamous Cell Carcinoma With Tumor Size ≤ 4 cm: A Retrospective Study

    by Kaige Pei, Dongmei Li, Mingrong Xi, Jiawen Zhang

    Objective: This study aimed to construct a nomogram incorporating preoperative laboratory parameters and clinical pathological factors for the first time to predict the probability of adjuvant therapy requirement following radical surgery in IB stage cervical squamous cell carcinoma (SCC) with tumor size ≤ 4 cm. Methods: Clinical pathological parameters and relevant laboratory indicators were collected from IB stage cervical SCC with tumor size ≤ 4 cm patients who underwent radical surgery at our hospital. Patients included in the study were randomly divided into a training set and a validation set in a 7:3 ratio. In the training set, the least absolute shrinkage and selection operator (LASSO) regression and multivariate logistic regression were used to determine the final variables for constructing the nomogram. Finally, the performance of the nomogram was evaluated using receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA) in both the training and validation sets. Results: The nomogram ultimately included seven predictive variables. The area under the ROC curve (AUC) for the nomogram in the training and validation sets was 0.863 and 0.767, respectively. Moreover, the calibration curve of the nomogram was relatively close to the ideal curve. The DCA showed that using the nomogram to predict the probability of adjuvant therapy requirement over a wide range of threshold values is beneficial. Conclusion: This study constructed and validated a model for predicting adjuvant therapy requirement in IB stage cervical SCC with tumor size ≤ 4 cm. The model can help clinicians determine the risk of postoperative adjuvant therapy before surgery, promoting personalized treatment choices and patient management.

  • Open Access

    The effect of marital status on cervical cancer related prognosis: a propensity score matching study

    by Kaige Pei, Mingrong Xi

    Cervical cancer is the fourth most common malignancy in women worldwide and the fourth leading cause of cancer death in women. Although an association between marital status and prognosis has been observed in a variety of malignancies, this link has not been fully elucidated in the field of cervical cancer. A total of 30,853 patients were enrolled in this study, of whom 14,286 (46.3%) were married and 16,567 (53.7%) were unmarried. The median follow-up time was 76 months. Before propensity score matching (PSM), cancer-specific survival (CSS) (HR = 1.55, 95% CI 1.49–1.61, p < 0.001) and overall survival (OS) (HR = 1.66, 95% CI 1.61–1.73, p < 0.001) in unmarried patients were significantly lower than those in married patients. After 1:1 PSM matching, there were 10,771 patients in each of the two groups, and baseline features were balanced (p > 0.05 for all variables). Even after PSM, CSS (HR = 1.07, 95% CI 1.02–1.13, p = 0.003) and OS (HR = 1.13, 95% CI 1.08–1.18, p < 0.001) of unmarried patients were significantly lower than those of married patients. Multivariate Cox regression analysis confirmed that unmarried status was an independent risk factor for CSS (HR = 1.12, 95% CI 1.07–1.17, p < 0.001) and OS (HR = 1.19, 95% CI 1.14–1.24, p < 0.001). Based on the large sample size analysis, this study revealed the association between unmarried status and poor prognosis of cervical cancer, and confirmed that marital status is an independent factor affecting the prognosis of cervical cancer. Nevertheless, more prospective studies and in-depth mechanistic studies are needed to validate our findings and explore the biological basis behind them.


  • Open Access

    Primary vulval sebaceous carcinoma: rare case report and literature review

    by Kaige Pei, Jiawen Zhang, Mingrong Xi

    This study presents a rare case of primary vulval sebaceous carcinoma (SC) and a literature review. Sebaceous carcinoma is an aggressive skin malignancy, predominantly periocular, with extraocular cases being particularly uncommon. We detail a 50-year-old female patient diagnosed with primary vulval SC, exhibiting a 0.5 cm white lesion on her left vulva. Despite initial drug therapy, the lesion progressed to ulceration and induration. Histopathological examination confirmed SC. The patient underwent extensive local vulvectomy and sentinel lymph node biopsy, showing no evidence of metastasis. At 22 months post-surgery, the patient remained recurrence-free. A literature review identified 13 additional cases, highlighting diverse presentations and management strategies. Our findings underscore the importance of sentinel lymph node biopsy and tailored surgical approaches for early-stage disease. The study contributes to the understanding of this rare condition and may inform future management protocols.


  • Simple Hysterectomy as a Viable Alternative to Radical Hysterectomy for Early-Stage Cervical Cancer: A Population-Based Cohort Study

    by Kaige Pei, Dongmei Li, Mingrong Xi

    This study aimed to assess the effect of simple hysterectomy compared with radical hysterectomy on cancer-specific survival and overall survival for patien


  • Open Access

    The impact of lymphadenectomy on cancerspecific survival in patients with low-grade endometrioid carcinoma of stage T1a

    by Kaige Pei, Dongmei Li, Mingrong Xi

    For patients with low-grade endometrioid carcinoma of stage T1a, the role of lymphadenectomy in staging surgery remains controversial. This study aims to evaluate the impact of lymphadenectomy on cancer-specific survival (CSS) in this patient population using a large, population-based dataset. We conducted a retrospective analysis using the Surveillance, Epidemiology, and End Results (SEER) database, identifying 11,014 patients with stage T1a, low-grade endometrioid carcinoma from 2004 to 2015. Patients were divided into lymphadenectomy and non-lymphadenectomy groups. Propensity score matching (PSM) was performed to balance baseline characteristics. Kaplan-Meier analysis, log-rank tests, and multivariate Cox regression were used to assess CSS and identify independent prognostic factors. Before PSM, the non-lymphadenectomy group had higher CSS compared to the lymphadenectomy group (HR = 1.56, 95% CI: 1.16–2.10, p = .003). After 1:1 PSM, CSS was similar between the two groups (HR = 1.09, 95% CI: 0.78–1.53, p = .605). Subgroup analyses showed no significant differences in CSS except for the subgroup with tumor size > 2 cm, where non-lymphadenectomy was associated with better CSS (HR = 0.50, p = .035). Multivariate Cox regression analysis identified age, marital status, histological grade, and chemotherapy as independent prognostic factors for CSS, while lymphadenectomy was not (p = .980).. Our findings suggest that lymphadenectomy does not improve CSS in patients with low-grade endometrioid carcinoma of stage T1a.


  • Open Access

    Risk of cervical intraepithelial neoplasia grade 3 or more diagnoses for human papillomavirus16/18-positive women by cytology and co-infection status

    by Mengyin Ao, Xiaoxi Yao, Danxi Zheng, Xuesai Gu, Mingrong Xi

    Background: Human papillomavirus (HPV) 16 and 18 cause approximately 70% of cervical cancer cases. The aim of this study was to evaluate whether co-infected with other HPV genotypes will affect the risk of cervical carcinogenesis in HPV16/18 positive-women. Methods: In this cross-sectional study, cervical cytology and histological classifications from women who tested positive for HPV 16/18 and underwent colposcopy within 6 months, between January 2010 and May 2021 were obtained from West China Second University Hospital of Sichuan University. Main outcomes and measures: Immediate risk of cervical intraepithelial neoplasia grade 3 or more diagnoses (CIN 3+). Results: A total of 7940 HPV 16/18-positive women were included, with a median age of 40 years (range 25–84 years). Among them, 2710 (34.1%) were infected with multiple genotypes, 6533 (82.28%) had cytology results and 2116 (26.65%) women were diagnosed with CIN 3+. The effects of HPV 16/18 coinfecting with other HPV on CIN3 + risk varied with specific HPV genotypes. After adjusting for cofactors, compared to single HPV 16 infection, the CIN 3 + risk was significantly reduced in women infected with HPV 16 + other high-risk HPV (hrHPV) [odds ratio (OR) = 0.621, 95% confidence interval (CI) 0.511–0.755], HPV 16 + low-risk HPV (lrHPV) (OR = 0.620, 95% CI 0.436–0.883), and HPV 16 + lrHPVs + other hrHPVs (OR = 0.248, 95% CI 0.157–0.391). The prevalence of CIN 3 + was associated with increased severity of cytologic abnormalities in HPV 16/18-positive women and peaked at cytology HSIL + (89.9% and 82.3%), which held a substantially greater risk than that of NILM (OR = 65.466, 95% CI 50.234–85.316). Conclusions: In this cross-sectional study of HPV 16/18-positive women, the effects of multiple infection were likely complicated and varied with specific HPV genotypes. The coinfection of HPV 16 and other genotypes of HPV except HPV 18 was associated with decreased CIN 3 + risk. Cytologic results were informative when HPV 16/18 was positive. It might be reasonable to recommend expedited treatment for patients with HPV 16/18 positive and HSIL + cytology in the Chinese population.


  • Open Access

    A comprehensive pan-cancer analysis identifies a novel glycolysis score and its hub genes as prognostic and immunological biomarkers

    by Danxi Zheng, Siyu Long, Mingrong Xi

    Background: Glycolysis plays significant roles in tumor progression and immune response. However, the exact role of glycolysis in prognosis and immune regulation has not been explored in all cancer types. This study first calculated a novel glycolysis score and screened out 12 glycolytic hub genes, and comprehensively analyzed molecular expression, clinical implications, and immune features of glycolysis among pan-cancer. Methods: The glycolysis score was derived by the single sample gene set enrichment analysis (ssGSEA) algorithm. The correlations of glycolysis with clinical parameters were analyzed using “limma” package. Downstream pathways of glycolysis were identified by Gene Set Enrichment Analysis (GSEA). The immune cell infiltration was explored and validated by three databases. The association between glycolysis and some immunotherapy biomarkers was explored by Pearson correlation analysis. Single-nucleotide variation (SNV), copy number variation (CNV), DNA methylation, and drug sensitivity analyses of 12 glycolytic hub genes were investigated. IMvigor210 and GSE91061 immunotherapeutic cohorts were retrieved to assess the ability of glycolysis score to predict immunotherapy efficacy. The expression of glycolysis key genes was detected in normal and endometrial cancer cell lines. Results: We found that glycolysis score was generally higher in tumor tissues compared to normal tissues and a high glycolysis score predominated as a risk prognostic factor. A high glycolysis score was associated with decreased immunostimulatory natural killer (NK) cells and CD8+ T cells infiltration, well increased immunosuppressive M2-tumor-associated macrophages (M2-TAM) cells infiltration. Tumor mutational burden (TMB), microsatellite instability (MSI), and immune checkpoints (ICPs) all closely interacted with glycolysis score and the frequency of gene mutation was confirmed to be higher in colon adenocarcinoma (COAD) patients with higher glycolysis score. The SNV, CNV, and DNA methylation of 12 glycolysis key genes occurred at different frequencies and showed different impacts on survival outcomes. The predictive and prognostic value of glycolysis score for immunotherapy outcomes was validated in two immunotherapy cohorts. The expression levels of key genes differ in normal endometrial and three endometrial cancer cell lines. Conclusions: This work indicated that glycolysis score and 12 glycolytic hub genes were correlated with an immunosuppressive microenvironment. They could be served as promising biomarkers aiding diagnosis, predicting prognosis and immunotherapy response for some tumor patients.


  • Open Access

    Case Report: Pelvic mass and massive ascites as the first symptom in cervical adenocarcinoma: report of two cases and literature review

    by Mingwei Yuan, Yan Zhang, Kana Wang, Mingrong Xi

    Cervical adenocarcinoma accounts for 10%–25% of total cases of cervical carcinoma. But in recent years, the incidence of adenocarcinoma has risen both proportionally and absolutely. Clinically, most cervical adenocarcinoma show no symptom or present with abnormal uterine bleeding or vaginal discharge, similar to squamous cell carcinoma. What different about it is that cervical cytological testing demonstrates a high false-negative rate of cervical adenocarcinoma, potentially leading to the failure in detecting in early stage. This report presents two cases both with pelvic masses, and massive ascites served as the initial symptom, which is similar to the clinical symptom of ovarian cancer, but ultimately diagnosed with cervical adenocarcinoma through surgical specimens. There are few literature reports on this situation. Hence, a literature review also has been performed to improve the recognition for cervical adenocarcinoma presenting with pelvic masses and massive ascites, and to avoid misdiagnosis.